Corneal Neovascularisation and Anti-VEGF Therapy
Targets · 10.03.2025 · 3 (1) · 9
DOI: 10.3390/targets3010009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Targets, online erschienen am 10.03.2025. Verfasst von Elsie Chan und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Melbourne Annemarie Mankiewicz-Zelkin Fellowship.
Abstract (Originalsprache)
Cornea vascularisation is a significant cause of ocular morbidity. Disease or injury often triggers the development of new blood vessels in the cornea, compromising its clarity and impairing vision. Common causes of corneal neovascularisation include infections, chemical burns, and local and systemic inflammatory disorders. Topical corticosteroid eye drops remain the standard therapy; however, extended use of corticosteroids has been known to cause side-effects including cataracts and raised intraocular pressure. As such, an alternative therapy has been actively sought. Vascular endothelial growth factor (VEGF) is a major angiogenic factor implicated in neovascularisation. The success of anti-VEGF agents in managing leaking blood vessels in neovascular age-related macular degeneration provides an opportunity to explore its use in the treatment of corneal neovascularisation. The therapeutic potential of anti-VEGF agents has been evaluated in experimental models of corneal neovascularisation and clinical trials with variable results. Here, we review the study results and discuss the development of new strategies that may improve treatment outcomes for corneal neovascularisation.
Förderung
- University of Melbourne Annemarie Mankiewicz-Zelkin Fellowship
Zitieren
APA
Chan, E., Gaskin, J. F., & Chan, E. C. (2025). Corneal Neovascularisation and Anti-VEGF Therapy. Targets, 3(1), 9. https://doi.org/10.3390/targets3010009
Vancouver
Chan E, Gaskin JF, Chan EC. Corneal Neovascularisation and Anti-VEGF Therapy. Targets. 2025;3(1):9. doi:10.3390/targets3010009
BibTeX
@article{Chan2025,
author = {Chan, Elsie and Gaskin, Jennifer Fan and Chan, Elsa C.},
title = {Corneal Neovascularisation and Anti-VEGF Therapy},
journal = {Targets},
year = {2025},
volume = {3},
number = {1},
pages = {9},
doi = {10.3390/targets3010009}
}
EUVIMED